KLK11 Mrna Expression Predicts Poor Disease-Free and Overall Survival in Colorectal Adenocarcinoma Patients

References

• Bray F , JemalA, GreyN, FerlayJ, FormanD. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study.Lancet Oncol.13 (8), 790 – 801 (2012).
   PubMed Web of Science ®Google Scholar
• Duffy MJ . Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?Clin. Chem.47 (4), 624 – 630 (2001).
   PubMed Web of Science ®Google Scholar
• Locker GY , HamiltonS, HarrisJet al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J. Clin. Oncol. 24 (33), 5313 – 5327 (2006).
   PubMed Web of Science ®Google Scholar
• Selby JV , FriedmanGD, QuesenberryCPJr, WeissNS. A case–control study of screening sigmoidoscopy and mortality from colorectal cancer.N. Engl. J. Med.326 (10), 653 – 657 (1992).
   PubMed Web of Science ®Google Scholar
• Yousef GM , ChangA, ScorilasA, DiamandisEP. Genomic organization of the human kallikrein gene family on chromosome 19q13.3–q13.4.Biochem. Biophys. Res. Commun.276 (1), 125 – 133 (2000).
   PubMed Web of Science ®Google Scholar
• Puente XS , SanchezLM, OverallCM, Lopez-OtinC. Human and mouse proteases: a comparative genomic approach.Nat. Rev. Genet.4 (7), 544 – 558 (2003).
   PubMed Web of Science ®Google Scholar
• Yousef GM , LuoLY, DiamandisEP. Identification of novel human kallikrein-like genes on chromosome 19q13.3–q13.4.Anticancer Res.19 (4B), 2843 – 2852 (1999).
   PubMed Web of Science ®Google Scholar
• Oikonomopoulou K , HansenKK, SaifeddineMet al. Proteinase-activated receptors, targets for kallikrein signaling. J. Biol. Chem. 281 (43), 32095 – 32112 (2006).
   PubMed Web of Science ®Google Scholar
• Oikonomopoulou K , HansenKK, SaifeddineMet al. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs). Biol. Chem. 387 (6), 817 – 824 (2006).
   PubMed Web of Science ®Google Scholar
• Ramsay AJ , ReidJC, AdamsMNet al. Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs). Biol. Chem. 389 (6), 653 – 668 (2008).
   PubMed Web of Science ®Google Scholar
• Nishibori M , MoriS, TakahashiHK. Physiology and pathophysiology of proteinase-activated receptors (PARs): PAR-2-mediated proliferation of colon cancer cell.J. Pharmacol. Sci.97 (1), 25 – 30 (2005).
   PubMed Web of Science ®Google Scholar
• Gratio V , BeaufortN, SeizLet al. Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells. Am. J. Pathol. 176 (3), 1452 – 1461 (2010).
   PubMed Web of Science ®Google Scholar
• Gratio V , LoriotC, VircaGDet al. Kallikrein-related peptidase 14 acts on proteinase-activated receptor 2 to induce signaling pathway in colon cancer cells. Am. J. Pathol. 179 (5), 2625 – 2636 (2011).
   PubMed Web of Science ®Google Scholar
• Macfarlane SR , SeatterMJ, KankeT, HunterGD, PlevinR. Proteinase-activated receptors.Pharmacol. Rev.53 (2), 245 – 282 (2001).
   PubMed Web of Science ®Google Scholar
• Oikonomopoulou K , HansenKK, SaifeddineMet al. Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more. Biol. Chem. 387 (6), 677 – 685 (2006).
   PubMed Web of Science ®Google Scholar
• Darmoul D , GratioV, DevaudH, LehyT, LaburtheM. Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.Am. J. Pathol.162 (5), 1503 – 1513 (2003).
   PubMed Web of Science ®Google Scholar
• Sano A , SangaiT, MaedaH, NakamuraM, HasebeT, OchiaiA. Kallikrein 11 expressed in human breast cancer cells releases insulin-like growth factor through degradation of IGFBP-3.Int. J. Oncol.30 (6), 1493 – 1498 (2007).
   PubMed Web of Science ®Google Scholar
• Emami N , DiamandisEP. Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers.Clin. Chem.54 (10), 1600 – 1607 (2008).
   PubMed Web of Science ®Google Scholar
• Kontos CK , MavridisK, TalieriM, ScorilasA. Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: mechanistic and clinical aspects.Thromb. Haemost.110 (3), 450 – 457 (2013).
   PubMed Web of Science ®Google Scholar
• Talieri M , LiL, ZhengYet al. The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer. Br. J. Cancer 100 (10), 1659 – 1665 (2009).
   PubMed Web of Science ®Google Scholar
• Avgeris M , MavridisK, ScorilasA. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.Biol. Chem.391 (5), 505 – 511 (2010).
   PubMed Web of Science ®Google Scholar
• Yu X , TangHY, LiXR, HeXW, XiangKM. Over-expression of human kallikrein 11 is associated with poor prognosis in patients with low rectal carcinoma.Med. Oncol.27 (1), 40 – 44 (2010).
   PubMed Web of Science ®Google Scholar
• Livak KJ , SchmittgenTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.Methods25 (4), 402 – 408 (2001).
   PubMed Web of Science ®Google Scholar
• Kheirelseid EA , ChangKH, NewellJ, KerinMJ, MillerN. Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer.BMC Mol. Biol.11, 12 (2010).
   PubMed Web of Science ®Google Scholar
• Dydensborg AB , HerringE, AuclairJ, TremblayE, BeaulieuJF. Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon.Am. J. Physiol. Gastrointest. Liver Physiol.290 (5), G1067 – G1074 (2006).
   PubMed Web of Science ®Google Scholar
• Bosman FT , CarneiroF, HrubanRH, TheiseND. WHO Classification of Tumours of the Digestive System.International Agency for Research on Cancer (IARC), Geneva, Switzerland (2010).
   Google Scholar
• Edge SB , ByrdDR, ComptonCC, FritzAG, GreeneFL, TrottiA. AJCC Cancer Staging Manual.Springer, NY, USA (2010).
   Google Scholar
• Camp RL , Dolled-FilhartM, RimmDL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.Clin. Cancer Res.10 (21), 7252 – 7259 (2004).
   PubMed Web of Science ®Google Scholar
• Chung DC . The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis.Gastroenterology119 (3), 854 – 865 (2000).
   PubMed Web of Science ®Google Scholar
• Mook OR , FrederiksWM, Van NoordenCJ. The role of gelatinases in colorectal cancer progression and metastasis.Biochim. Biophys. Acta1705 (2), 69 – 89 (2004).
   PubMed Web of Science ®Google Scholar
• Liotta LA , KohnEC. The microenvironment of the tumour–host interface.Nature411 (6835), 375 – 379 (2001).
   PubMed Web of Science ®Google Scholar
• Borgono CA , DiamandisEP. The emerging roles of human tissue kallikreins in cancer.Nat. Rev. Cancer4 (11), 876 – 890 (2004).
   PubMed Web of Science ®Google Scholar
• Inoue Y , YokoboriT, YokoeTet al. Clinical significance of human kallikrein7 gene expression in colorectal cancer. Ann. Surg. Oncol. 17 (11), 3037 – 3042 (2010).
   PubMed Web of Science ®Google Scholar
• Kontos CK , ChantzisD, PapadopoulosIN, ScorilasA. Kallikrein-related peptidase 4 (KLK4) mRNA predicts short-term relapse in colorectal adenocarcinoma patients.Cancer Lett.330 (1), 106 – 112 (2013).
   PubMed Web of Science ®Google Scholar
• Alexopoulou DK , PapadopoulosIN, ScorilasA. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer. Clin. Biochem.46 (15), 1453 – 1461 (2013).
   PubMed Web of Science ®Google Scholar
• Nagahara H , MimoriK, UtsunomiyaTet al. Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer. Clin. Cancer Res. 11 (19 Pt 1), 6800 – 6806 (2005).
   PubMed Web of Science ®Google Scholar
• Florou D , MavridisK, ScorilasA. The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents. Tumour Biol.33 (6), 2069 – 2078 (2012).
   PubMedGoogle Scholar
• Linardoutsos D , AvgerisM, BramisJ, ZografosGC, A. S. Expression analysis of kallikrein-related peptidase 4 gene (KLK4) in pancreatic cancer. Presented at : 4th International Symposium on Kallikreins and Kallikrein-Related Peptidases.Rhodes, Greece, 2–4September 2011.
   Google Scholar
• Ruckert F , HennigM, PetrakiCDet al. Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma. Br. J. Cancer 99 (9), 1484 – 1492 (2008).
   PubMed Web of Science ®Google Scholar
• Dlamini Z , BhoolaKD. Upregulation of tissue kallikrein, kinin B1 receptor, and kinin B2 receptor in mast and giant cells infiltrating oesophageal squamous cell carcinoma.J. Clin. Pathol.58 (9), 915 – 922 (2005).
   PubMed Web of Science ®Google Scholar
• Yousef GM , BorgonoCA, WhiteNMet al. In silico analysis of the human kallikrein gene 6. Tumour Biol. 25 (5–6), 282 – 289 (2004).
   PubMedGoogle Scholar
• Bhattacharjee A , RichardsWG, StauntonJet al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl Acad. Sci. USA 98 (24), 13790 – 13795 (2001).
   PubMed Web of Science ®Google Scholar
• Planque C , ChoiYH, GuyetantS, Heuze-Vourc’hN, BriollaisL, CourtyY. Alternative splicing variant of kallikrein-related peptidase 8 as an independent predictor of unfavorable prognosis in lung cancer.Clin. Chem.56 (6), 987 – 997 (2010).
   PubMed Web of Science ®Google Scholar
• Planque C , KulasingamV, SmithCR, ReckampK, GoodglickL, DiamandisEP. Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.Mol. Cell. Proteomics8 (12), 2746 – 2758 (2009).
   PubMed Web of Science ®Google Scholar
• Chung CH , ParkerJS, KaracaGet al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5 (5), 489 – 500 (2004).
   PubMed Web of Science ®Google Scholar
• Zhao H , DongY, QuanJet al. Correlation of the expression of human kallikrein-related peptidases 4 and 7 with the prognosis in oral squamous cell carcinoma. Head Neck 33 (4), 566 – 572 (2011).
   PubMed Web of Science ®Google Scholar
• Avgeris M , MavridisK, ScorilasA. Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance.Biol. Chem.393 (5), 301 – 317 (2012).
   PubMed Web of Science ®Google Scholar
• Sidiropoulos M , PampalakisG, SotiropoulouG, KatsarosD, DiamandisEP. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.Tumour Biol.26 (6), 324 – 336 (2005).
   PubMedGoogle Scholar
• Pampalakis G , SotiropoulouG. Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer.Biol. Chem.387 (6), 773 – 782 (2006).
   PubMed Web of Science ®Google Scholar
• Talieri M , AlexopoulouDK, ScorilasAet al. Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer. Tumour Biol. 32 (4), 737 – 744 (2011).
   PubMedGoogle Scholar
• Talieri M , MathioudakiK, PrezasPet al. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer. Thromb. Haemost. 101 (4), 741 – 747 (2009).
   PubMed Web of Science ®Google Scholar
• Shigemasa K , GuL, TanimotoH, O’BrienTJ, OhamaK. Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer. Clin. Cancer Res.10 (8), 2766 – 2770 (2004).
   PubMed Web of Science ®Google Scholar
• Stavropoulou P , GregorakisAK, PlebaniM, ScorilasA. Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer.Clin. Chim. Acta357 (2), 190 – 195 (2005).
   PubMed Web of Science ®Google Scholar
• Scorilas A , GregorakisAK. mRNA expression analysis of human kallikrein 11 (KLK11) may be useful in the discrimination of benign prostatic hyperplasia from prostate cancer after needle prostate biopsy.Biol. Chem.387 (6), 789 – 793 (2006).
   PubMed Web of Science ®Google Scholar
• Nakamura T , StephanC, ScorilasA, YousefGM, JungK, DiamandisEP. Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues. Urology61 (5), 1042 – 1046 (2003).
   PubMed Web of Science ®Google Scholar
• Loeb S , CatalonaWJ. Prostate-specific antigen in clinical practice.Cancer Lett.249 (1), 30 – 39 (2007).
   PubMed Web of Science ®Google Scholar
• Stephan C , CammannH, MeyerHA, LeinM, JungK. PSA and new biomarkers within multivariate models to improve early detection of prostate cancer.Cancer Lett.249 (1), 18 – 29 (2007).
   PubMed Web of Science ®Google Scholar
• Borgono CA , FracchioliS, YousefGMet al. Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma. Int. J. Cancer 106 (4), 605 – 610 (2003).
   PubMed Web of Science ®Google Scholar
• Kontos CK , ChantzisD, PapadopoulosIN, ScorilasA. Quantitative expression analysis and prognostic significance of KLK4 mRNA expression in colon cancer. Presented at : 3rd International Symposium on Kallikreins and Kallikrein-Related Peptidases.Munich, Germany, 28 September–1 October 2009.
   Google Scholar
• Devetzi M , TrangasT, ScorilasA, XynopoulosD, TalieriM. Parallel overexpression and clinical significance of kallikrein-related peptidases 7 and 14 (KLK7KLK14) in colon cancer.Thromb. Haemost.109 (4), 716 – 725 (2013).
   PubMed Web of Science ®Google Scholar
• Feng B , XuWB, ZhengMHet al. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer. J. Gastroenterol. Hepatol. 21 (10), 1596 – 1603 (2006).
   PubMed Web of Science ®Google Scholar
• Talieri M , DiamandisEP, GourgiotisD, MathioudakiK, ScorilasA. Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma.Thromb. Haemost.91 (1), 180 – 186 (2004).
   PubMed Web of Science ®Google Scholar
• Ogawa K , UtsunomiyaT, MimoriKet al. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin. Cancer Res. 11 (8), 2889 – 2893 (2005).
   PubMed Web of Science ®Google Scholar